- Home
- / Nanjing Hicin Pharmaceutical
Nanjing Hicin Pharmaceutical
Stock Price
¥22.6
2024-10-29
Market Capitalization
¥2.6 B
2024-10-29
Revenue
¥491.5 M
FY, 2024
Nanjing Hicin Pharmaceutical Summary
Company Summary
- Overview
- Nanjing Hicin Pharmaceutical (南京海欣药业) is a company that produces and markets pharmaceutical preparations and synthetic chemical products. It offers thymopentin injections, mizoribine tablets, pidotimod capsules, glucosamine sulfate granules, and other products.
- Type
- Public
- Status
- Active
- Founded
- 2003
- HQ
- Nan Jing Shi, CN | view all locations
- Website
- http://www.hicin.cn
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Nan Jing Shi, Jiang Su Sheng HQ
China
100 Xin Gang Da Dao, Qi Xia Qu
Nanjing Hicin Pharmaceutical Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥156.7M
- Gross profit (Q1, 2026)
- ¥122.2M
- Net income (Q1, 2026)
- ¥16.3M
- Cash (Q1, 2026)
- ¥71.2M
- EBIT (Q1, 2026)
- ¥17.9M
- Enterprise value
- $2.9B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026